Protective effect of combined use of standard drug therapy and spironolactone against arrhythmia and heart failure in patients with acute ST-segment elevated myocardial infarction after emergency percutaneous coronary intervention

Author:

Wang Rongrong,Zheng Yuanxi,Chen Liangchuan

Abstract

Purpose: To determine the mitigating impact of standardized drug therapy in combination with spironolactone on arrhythmia and heart failure in subjects with severe ST-segment elevation myocardial infarction (STEMI) following exigency percutaneous coronary intervention (PCI). Methods: 120 severe STEMI subjects who underwent exigency PCI were assigned to control and study groups, with 60 patients in each group. Control group received long-term aspirin therapy (85 mg/day, orally) after emergency PCI, while study group received long-term spironolactone therapy (50 mg/day, orally) plus control cohort drug regimen. Treatment effectiveness, heart function, quality of life, electrolyte levels (K+ and Mg2+), and incidence of cardiac adverse events were determined before and post-treatment. Results: Treatment efficacy was markedly greater in study cohort. Post-treatment values of LVEF indicators in both groups were significantly greater than the pre-treatment levels, with markedly higher study cohort levels. In contrast, values of LVEDD and LVESD indicators were significantly reduced in both groups after treatment, but the levels in study group were significantly lower (p < 0.05). Scores on indices of physical function, psychological function, social function, and physical quality of life in both groups were significantly increased after treatment, with significantly higher scores in study cohort (p < 0.05). Post-therapy serum concentrations of K+ and Mg2+ were markedly raised in both groups but with higher levels in study cohort. Incidents of unwanted heart situations were lower in study cohort. Conclusion: Combined use of standard drugs and spironolactone for the treatment of severe STEM1 subjects following emergency PCI is effective. More studies are required to elaborate the mechanistic characteristics of this combination.

Publisher

African Journals Online (AJOL)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3